1. Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma‐derived FVIII and usefulness of a specific standard in ReFacto AF®‐treated patients. (29th January 2016) Authors: Pouplard, C.; Ternisien, C.; Desconclois, C.; Lasne, D.; Aillaud, M.‐F.; Caron, C. Journal: Haemophilia Issue: Volume 22:Number 2(2016:Mar.) Page Start: e101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Does the presence of von Willebrand factor in FVIII‐deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?. (12th May 2014) Authors: Pouplard, C.; Desconclois, C.; Sobas, F.; Aillaud, M. F.; Ternisien, C.; Caron, C. Journal: International journal of laboratory hematology Issue: Volume 37:Number 1(2015:Feb.) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Thrombocytopenia in pregnant patients with mild COVID-19. (November 2020) Authors: Le Gouez, A.; Vivanti, A.J.; Benhamou, D.; Desconclois, C.; Mercier, F.J. Journal: International journal of obstetric anesthesia Issue: Volume 44(2020) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗